Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc. Continues Sales Expansion; Signs Contract to Implement Microsoft-Based Digital Prescription Software and Call Center Services for Dr. Patricia A. Alessi
Contract Supports $10 Million 2008 Revenue Goal
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - May 13, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) announced today that the Company has signed a contract with Dr.
Patricia A. Alessi of Alessi Family Care in Bonita Springs, Florida to
implement the Company's Microsoft-based digital prescription handling
software, digiRX and digiReauth, and to supply call center services to
support the reauthorization of prescriptions.
Dr. Alessi earned her medical degree from Nova Southeastern University
College of Osteopathic Medicine and is a member of the American College of
Osteopathic Family Practitioners, American Osteopathic Association and the
Florida Osteopathic Association.
Each new doctor contract can add hundreds of patients to the digiRX
network, who in turn drive prescription sales into company owned pharmacies
and increase company revenue. digiMedical is actively expanding their
regional footprint in the Naples area in support of the 2008 revenue goal
of $10 million. This contract follows multiple recent contracts with
doctors in the area, to include Dr. Moorthy of Pain Management Center of
Naples, Dr. Shardul Nanavati, founder of Advanced Gastroenterology, Drs.
Romero, Tineo and Seibert of Oaktree Family Practice, Orthopedic Surgeon
Dr. Howard Kapp of Anchor Health Centers, Drs. Santos-Ocampo, Axline and
Spilker of the Collier Heart Group, the Medical Director of Vanish Vein and
Laser Center and Dr. Wey of the Neuroscience and Spine Associates in
Naples, Florida.
digiMedical Prescription Handling Software and Pharmacies
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
Company Fact Sheet and Updates
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to receive a Fact Sheet on the company, please send
an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc. ™
digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and
medical technology company focused on developing next generation digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'™ unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as "Forward-Looking
Statements" for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate," "await," "envision,"
"foresee," "aim at," "believe," "intends," "estimates" including without
limitation, those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual results
to differ materially from those indicated in the Forward-Looking
Statements. Readers are directed to the company's filings with the U.S.
Securities and Exchange Commission for additional information and a
presentation of the risks and uncertainties that may affect the company's
business and results of operations.